F8 and hemophilia A: In severe hemophilia A (SHA), anti-FVIII NNAs were most frequently observed in patients with a history of inhibitor, and the presence of NNAs in patients who were not previously exposed to FVIII concentrates was associated with an increased risk of inhibitor development [6,7].